U.S. allows 1st emergency use of a COVID-19 antibody drug

Southwest Life

U.S. allows 1st emergency use of a COVID-19 antibody drug

On Monday, Nov. 9, 2020, the Food and Drug Administration cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.

U.S. allows 1st emergency use of a COVID-19 antibody drug

On Monday, Nov. 9, 2020, the Food and Drug Administration cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.
Listen
Loading the English audio player...
Escuchar en Español:
Loading the Español audio player...
click here to add your event
Area Events